Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001009448-18-000001
Filing Date
2018-04-10
Accepted
2018-04-10 12:50:25
Documents
1
Effectiveness Date
2018-04-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10541
  Complete submission text file 0001009448-18-000001.txt   11716
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: D | Act: 33 | File No.: 021-309749 | Film No.: 18747471